PRKAG3 and sarcoidosis: While metformin was found to interact with PRKAG3, a gene significantly altered in both conditions, and exhibited cytotoxic effects on LC cells, the extent to which it might prevent malignant progression in high-risk sarcoidosis patients remains to be identified.